Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Martin Makary

‘Do you want FDA approval?’: Trump wins over Joe Rogan by green-lighting a drug research idea he had from a podcast

Here is the most random way to get policy greenlit.

We Got This Covered

What is Joe Rogan doing in the White House? Trump invites podcaster and calls him 'liberal'

Joe Rogan’s appearance at the White House alongside Donald Trump has raised eyebrows, after the MAGA podcast host joined the president during the signing of an executive order focused on psychedelic drug research for mental health treatment.

The Times of India

Trump and RFK Jr touted leucovorin as a treatment for autism. The FDA quietly walked it back

Outpatient prescriptions for the drug increased 71% after news, but FDA later approved it only for folate deficiency

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Ex-FDA workers warn Trump cuts will increase risk of food safety lapses in US

Current and former workers caution administration’s ‘politicization of science’ will negatively affect Americans

The Guardian - US

RFK Jr. orders abortion pill ‘safety review’ based on junk science – just like his Tylenol autism claims

Guess which conservative think tank supplied the "evidence" for this one...

We Got This Covered

What is leucovorin, the drug the FDA approved to treat autism?

This week the FDA approved the generic drug as a treatment for autism – a move that shocked health experts

The Guardian - US

Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks

Food and Drug Administration Commissioner Martin Makary stated on Friday that Hims Hers Health Inc. (NYSE:HIMS) broke federal law with its Super Bowl commercial promoting weight-loss drugs.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

FDA won’t approve COVID shot for healthy, non-elderly population - Roll Call

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

Roll Call

FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The Conversation

The Trump administration is defending abortion pill access in court. What?

It may seem a victory to some, but experts worry a win will allow the government to be coy about future attacks

The Guardian - US

Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’

Rare admonition from a sector that has largely been silent in the face of the second Trump administration

The Guardian - US

HHS to cut 10,000 jobs, ‘streamline’ operations - Roll Call

The department outlined plans to cut 10,000 jobs, in addition to the about 10,000 employees who left voluntarily earlier this year.

Roll Call

Trump administration at ‘war’ with mRNA technology: scientists alarmed vaccine skeptics could kill research

Public health experts are sounding the alarm over recent move by the NIH to collect information about funding for research into mRNA technology

The Guardian - US

Senate confirms Makary for FDA commissioner - Roll Call

FDA pick, a former Johns Hopkins surgeon, seen as a less controversial nomination than some of Trump's other HHS subagency selections.

Roll Call

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

Congress returns for three-week sprint session - Roll Call

Both the House and Senate come back from recess this week to begin a busy three-week period that’s expected to focus on Republicans’ budget reconciliation agenda, including extending and expanding tax cuts and tightening immigration policy. The top items on the House agenda this week, meanwhile, will include more measures…

Roll Call

Makary tells Senate panel he plans to review FDA job cuts - Roll Call

FDA nominee Martin Makary was asked about abortion drugs, vaccine panels during a Senate hearing on his bid to lead the agency.

Roll Call

FDA pick may differ from HHS head RFK Jr. in some key areas - Roll Call

Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health issues.

Salon

Trump's post-COVID brain drain

Donald Trump is out for COVID revenge

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

the Food and Drug Administration

209 stories

The National Institutes of Health

150 stories

the Department of Health and Human Services

138 stories

Johns Hopkins University

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.